MedPath

A back pain checklist (Vfrac) for use in primary care to identify older women with back pain due to un-diagnosed broken bones in the back

Not Applicable
Completed
Conditions
Osteoporotic vertebral fracture
Musculoskeletal Diseases
Osteoporosis
Registration Number
ISRCTN16550671
Lead Sponsor
niversity of Bristol
Brief Summary

2019 Protocol article in https://pubmed.ncbi.nlm.nih.gov/30684069/ protocol (added 25/03/2019) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35284926/ results (added 19/06/2023)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
1635
Inclusion Criteria

1. Willing and able to give informed consent for participation in the study
2. Self-reported back pain in the previous 4 months
3. Aged over 65 years

Exclusion Criteria

Current exclusion criteria as of 23/01/2019:
1. Aged 65 years or under
2. No self-reported back pain reported in the previous 4 months
3. Has already had a full spinal x-ray in the previous 4 months that is not available to the research team
4. Considered unsuitable to take part by their GP (e.g. cognitive impairment or near end of life)

Previous exclusion criteria:
1. Aged 65 years or under
2. No self-reported back pain reported in the previous 4 months
3. Has already had a full spinal x-ray in the previous 4 months
4. Considered unsuitable to take part by their GP (e.g. cognitive impairment or near end of life)

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome measure will be the accuracy of the Vfrac tool as estimated by the sensitivity and specificity. We are aiming for a sensitivity and specificity of greater than 80% to justify subsequent exploration in a definitive trial. The method of measurement will be self-reported questionnaire data at recruitment followed by data collection in research clinic plus spinal radiograph as soon as possible after recruitment.
Secondary Outcome Measures
NameTimeMethod
<br> 1. Cost effectiveness of Vfrac based upon follow-up of women from the primary outcome cohort to identify if a future definitive cluster randomised controlled trial is appropriate<br> 2. Sources of variance that can be tested in a pilot as part of a future bid<br> 3. Stopping rules for a future trial. The output of this will be a decision on whether a future definitive trial is warranted.<br>
© Copyright 2025. All Rights Reserved by MedPath